Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
18–79
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosed with RLS using the International RLS Study Group Diagnostic Criteria with a total score of 15 or greater on the International RLS Rating Scale.
Have evening and nighttime symptoms of RLS, significant sleep impairment due to RLS symptoms, and symptoms requiring treatment prior to bedtime, but no earlier than 5:00PM.
You may not be if
Have secondary RLS.
Have any medical conditions that may impact efficacy assessments or that may present a safety concern.
Clareo Health | Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome
